AEGiS-Reuters: HIV on rise among self-injecting drug users -study

Reuters, Ltd.Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


HIV on rise among self-injecting drug users -study

Reuters NewMedia - September 23, 2008
Michael Kahn


LONDON, Sept 24 (Reuters) - The rate of HIV infection among people who inject themselves with drugs appears to be rising, according to a study published on Wednesday.

An estimated 3 million self-injecting drug users worldwide may be HIV positive, said the analysis of peer-reviewed studies and data from United Nations agencies and international experts.

It identified injected drug use in 148 countries and found HIV infections among these kind of users topped 40 percent in nine nations: Estonia, Ukraine, Myanmar (Burma), Indonesia, Thailand, Nepal, Argentina, Brazil and Kenya.

"The new data do suggest increases in both the number of injecting drug users and the prevalence of HIV in users," Kamyar Arasteh and Don Des Jarlais of Beth Israel Medical Centre in New York wrote in a commentary about the study published in the medical journal Lancet.

They said there may be time to educate people in countries where injecting drug use is common but the virus has not yet begun infecting users to a large degree.

Used syringes can spread HIV. Infected drug users are also more likely to engage in risky behaviour such as unprotected sex that can spread the virus that causes AIDS.

The researchers estimated that in 2007 nearly 16 million people around the world injected drugs, with China, the United States and Russia having the largest number of such users.

They also noted there was little data from places in Africa but said Southeast Asia, eastern Europe, and Latin America were areas of worry.

GLOBAL CHALLENGE

"Injecting drug use occurs in most countries and HIV infection is prevalent among many populations of injecting drug users, representing a major challenge to global health," Bradley Mathers of the National Drug and Alcohol Research Centre in Australia and colleagues wrote.

The review showed big differences worldwide. For example, in Britain 0.4 percent of people aged 15 to 64 injected drugs, with 2.3 percent of them estimated to be HIV positive.

In Spain the proportion of addicts is lower at 0.31 percent but nearly 40 percent of them have HIV, the highest proportion in Europe, the researchers said.

Australia and New Zealand have maintained a very low level of HIV infection even though they have more injected drug users, something the researchers attributed to swift introduction of needle and syringe exchange programs in the 1980s.

They also cited Estonia as a country representative of the quick spread of HIV infections among drug users in recent years.

"A decade ago HIV was not identified among people who inject drugs in Estonia," the researchers said. "A more recent estimate now suggests that the prevalence of HIV infection in some populations has reached 72 percent in one sample of injecting drug users."

(Reporting by Michael Kahn; Editing by Maggie Fox and Mark Trevelyan)

Reference

Mathers B.M. et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. The Lancet (online edition), September 24th, 2008.

Arasteh K. et al. Injecting drug use, HIV, and what to do about it. The Lancet (online edition), September 24th, 2008.


080923
RE080928


Copyright © 2008 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .